CareDx, Inc.

9.73 USD
-0.03 (-0.31%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CareDx, Inc. stock is up 79.85% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 November’s closed higher than October. 100% of analysts rate it a buy.

About CareDx, Inc.

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.